
|Articles|August 1, 2002
Government takes pro Maine prescription position
Although the Bush Administration, in the person of the Solicitor General, filed a brief with the U.S. Supreme Court suggesting that it refuse to hear an appeal from the Pharmaceutical Research and Manufacturers of America (PhRMA) on Maine's Rx prescription law, the court agreed to hear the case.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Updates iPLEDGE REMS with New Modifications for Pregnancy Testing and Prescription Windows
2
New Phase 3 DISCREET Data Supports Long-Term Use of Apremilast for Genital Psoriasis
3
Phase 3 Results Signal a New Era for Oral Targeted Therapy in Psoriasis
4
Christopher Bunick, MD, PhD, on Expanding Targets in Inflammatory Skin Disease
5










